| 臺大學術典藏 |
2022-04-28T12:31:39Z |
2017 Taiwan lipid guidelines for high risk patients
|
Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; KUO-LIONG CHIEN; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; Wu C.-C.; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2022-04-28T12:31:31Z |
Erratum: ��Corrigendum to ��2017 Taiwan lipid guidelines for high risk patients�� [Journal of the Formosan Medical Association (2017) [217�V248]��(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; KUO-LIONG CHIEN; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; Wu C.-C.; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2021-12-22T03:54:05Z |
Pharmacogenetic dosing of warfarin in the Han-Chinese population: A randomized trial
|
Wen M.-S.; Chang K.-C.; Lee T.-H.; Chen Y.-F.; Hung K.-C.; Chang Y.-J.; Liou C.-W.; Chen J.-J.; Chang C.-H.; Wang C.-Y.; JIANN-SHING JENG; Chuang H.-P.; Chen Y.-T.; Chen C.-H.; Wu J.-Y.; Chen Y.-T.; Lee M.T.M. |
| 臺大學術典藏 |
2021-12-22T03:54:04Z |
2017 Taiwan lipid guidelines for high risk patients
|
Li Y.-H.; Ueng K.-C.; JIANN-SHING JENG; Charng M.-J.; Lin T.-H.; Chien K.-L.; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; Wu C.-C.; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2021-12-22T03:53:55Z |
Erratum: ‘Corrigendum to “2017 Taiwan lipid guidelines for high risk patients” [Journal of the Formosan Medical Association (2017) [217–248]’(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H.; Ueng K.-C.; JIANN-SHING JENG; Charng M.-J.; Lin T.-H.; Chien K.-L.; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; Wu C.-C.; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2021-05-07T06:02:40Z |
Midlife risk factors for subtypes of dementia: A nested case-control study in Taiwan
|
Chun-Ju Chiang;Yip P.-K.;Wu S.-C.;Lu C.-S.;Liou C.-W.;Liu H.-C.;Liu C.-K.;Chu C.-H.;Hwang C.-S.;Sung S.-F.;Hsu Y.-D.;Chen C.-C.;Liu S.-I.;Yan S.-H.;Fong C.-S.;Chang S.-F.;You S.-L.;Chen C.-J.; CHUN-JU CHIANG; Yip P.-K.; Wu S.-C.; Lu C.-S.; Liou C.-W.; Liu H.-C.; Liu C.-K.; Chu C.-H.; Hwang C.-S.; Sung S.-F.; Hsu Y.-D.; Chen C.-C.; Liu S.-I.; Yan S.-H.; Fong C.-S.; Chang S.-F.; You S.-L.; Chen C.-J. |
| 臺大學術典藏 |
2020-11-03T11:44:48Z |
Pharmacogenetic dosing of warfarin in the Han-Chinese population: A randomized trial
|
Lee M.T.M.; Chen Y.-T.; Wu J.-Y.; Chen C.-H.; Chen Y.-T.; Chuang H.-P.; JIANN-SHING JENG; Wang C.-Y.; Chang C.-H.; Chen J.-J.; Liou C.-W.; Chang Y.-J.; Hung K.-C.; Chen Y.-F.; Lee T.-H.; Chang K.-C.; Wen M.-S.; Wen M.-S.;Chang K.-C.;Lee T.-H.;Chen Y.-F.;Hung K.-C.;Chang Y.-J.;Liou C.-W.;Chen J.-J.;Chang C.-H.;Wang C.-Y.;Jiann-Shing Jeng;Chuang H.-P.;Chen Y.-T.;Chen C.-H.;Wu J.-Y.;Chen Y.-T.;Lee M.T.M. |
| 臺大學術典藏 |
2020-11-03T11:44:46Z |
2017 Taiwan lipid guidelines for high risk patients
|
The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients; Yeh H.-I.; Wu C.-C.; Chen J.-W.; Yu T.-Y.; Lee C.-C.; Liou C.-W.; Tang S.-C.; Chien S.-C.; Liu P.-Y.; Su C.-H.; Chien K.-L.; Lin T.-H.; Charng M.-J.; JIANN-SHING JENG; Ueng K.-C.; Li Y.-H.; Li Y.-H.;Ueng K.-C.;Jiann-Shing Jeng;Charng M.-J.;Lin T.-H.;Chien K.-L.;Wang C.-Y.;Chao T.-H.;Liu P.-Y.;Su C.-H.;Chien S.-C.;Liou C.-W.;Tang S.-C.;Lee C.-C.;Yu T.-Y.;Chen J.-W.;Wu C.-C.;Yeh H.-I.;The Writing Group Of 2017 Taiwan Lipid Guidelines For High Risk Patients; Chao T.-H.; Wang C.-Y. |
| 臺大學術典藏 |
2020-11-03T11:08:10Z |
2017 Taiwan lipid guidelines for high risk patients
|
Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; SUNG-CHUN TANG; Lee C.-C.; Yu T.-Y.; Chen J.-W.; Wu C.-C.; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients; Chien K.-L.; Wang C.-Y.; Charng M.-J.; Lin T.-H.; Jeng J.-S.; Li Y.-H.; Ueng K.-C.; Li Y.-H.;Ueng K.-C.;Jeng J.-S.;Charng M.-J.;Lin T.-H.;Chien K.-L.;Wang C.-Y.;Chao T.-H.;Liu P.-Y.;Su C.-H.;Chien S.-C.;Liou C.-W.;Sung-Chun Tang;Lee C.-C.;Yu T.-Y.;Chen J.-W.;Wu C.-C.;Yeh H.-I.;The Writing Group Of 2017 Taiwan Lipid Guidelines For High Risk Patients |
| 臺大學術典藏 |
2020-11-03T11:08:02Z |
Erratum: ‘Corrigendum to “2017 Taiwan lipid guidelines for high risk patients” [Journal of the Formosan Medical Association (2017) [217–248]’(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients; Liu P.-Y.; Chao T.-H.; Wang C.-Y.; Chien K.-L.; Lin T.-H.; Charng M.-J.; Jeng J.-S.; Li Y.-H.;Ueng K.-C.;Jeng J.-S.;Charng M.-J.;Lin T.-H.;Chien K.-L.;Wang C.-Y.;Chao T.-H.;Liu P.-Y.;Su C.-H.;Chien S.-C.;Liou C.-W.;Sung-Chun Tang;Lee C.-C.;Yu T.-Y.;Chen J.-W.;Wu C.-C.;Yeh H.-I.;The Writing Group Of 2017 Taiwan Lipid Guidelines For High Risk Patients; Li Y.-H.; Ueng K.-C.; Yeh H.-I.; Wu C.-C.; Yu T.-Y.; Chen J.-W.; SUNG-CHUN TANG; Lee C.-C.; Liou C.-W.; Chien S.-C.; Su C.-H. |
| 臺大學術典藏 |
2020-06-01T09:06:40Z |
Erratum: ‘Corrigendum to “2017 Taiwan lipid guidelines for high risk patients” [Journal of the Formosan Medical Association (2017) [217–248]’(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H.;Ueng K.-C.;Jeng J.-S.;Charng M.-J.;Lin T.-H.;Chien K.-L.;Chih-Yuan Wang;Chao T.-H.;Liu P.-Y.;Su C.-H.;Chien S.-C.;Liou C.-W.;Tang S.-C.;Lee C.-C.;Yu T.-Y.;Chen J.-W.;Wu C.-C.;Yeh H.-I.;The Writing Group Of 2017 Taiwan Lipid Guidelines For High Risk Patients; Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; Chien K.-L.; CHIH-YUAN WANG; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients; Yeh H.-I.; Wu C.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-05T03:20:19Z |
Erratum: 2-Deoxyglucose treatment complements the cisplatin- or BH3-onlymimetic-induced suppression of neuroblastoma cell growth (International Journal of Biochemistry and Cell Biology (2013) 45 (944-951))
|
Chou M.-H.; Tai M.-H.; Lin T.-K.; Liou C.-W.; Chen T.; WEN-MING HSU; Wang P.-W.; Chuang J.-H. |
| 臺大學術典藏 |
2020-03-05T03:20:17Z |
2-Deoxyglucose treatment complements the cisplatin- or BH3-only mimetic-induced suppression of neuroblastoma cell growth
|
Chuang J.-H.; Chou M.-H.; Tai M.-H.; Lin T.-K.; Liou C.-W.; Chen T.; WEN-MING HSU; Wang P.-W. |
| 臺大學術典藏 |
2020-03-05T03:20:10Z |
Glycolytic inhibitor 2-deoxyglucose simultaneously targets cancer and endothelial cells to suppress neuroblastoma growth in mice
|
Huang C.-C.;Wang S.-Y.;Lin L.-L.;Wang P.-W.;Chen T.-Y.;Wen-Ming Hsu;Lin T.-K.;Liou C.-W.;Chuang J.-H.; Huang C.-C.; Wang S.-Y.; Lin L.-L.; Wang P.-W.; Chen T.-Y.; WEN-MING HSU; Lin T.-K.; Liou C.-W.; Chuang J.-H. |
| 臺大學術典藏 |
2020-03-04T09:03:06Z |
2017 Taiwan lipid guidelines for high risk patients
|
Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; Chien K.-L.; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; CHAU-CHUNG WU; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-04T09:03:03Z |
Erratum: ‘Corrigendum to “2017 Taiwan lipid guidelines for high risk patients” [Journal of the Formosan Medical Association (2017) [217–248]’(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; Chien K.-L.; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; CHAU-CHUNG WU; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-04T05:42:45Z |
2017 Taiwan lipid guidelines for high risk patients
|
The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients; Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I |
| 臺大學術典藏 |
2020-03-04T05:42:38Z |
Erratum: ��Corrigendum to ��2017 Taiwan lipid guidelines for high risk patients�� [Journal of the Formosan Medical Association (2017) [217�V248]��(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-02T12:10:57Z |
2017 Taiwan lipid guidelines for high risk patients
|
Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-02T12:10:46Z |
Erratum: ��Corrigendum to ��2017 Taiwan lipid guidelines for high risk patients�� [Journal of the Formosan Medical Association (2017) [217�V248]��(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 國立成功大學 |
2020 |
Association between keratoconus and the risk of adolescent- or adult-onset atopic dermatitis
|
Chang, Y.-S.;Weng, S.-F.;Wang, J.-J.;Tseng, S.-H.;Wang, J.-Y.;Jan, H.-Y.;Ko, S.-Y.;Tsai, W.-H.;Chen, H.-Y.;Liou, C.-W.;Jan, R.-L. |
| 國立成功大學 |
2020 |
Nutritional status associated with molecular biomarkers, physiological indices, and clinical severity in parkinson’s disease patients
|
Lin, T.-K.;Chang, Y.-Y.;Chen, N.-C.;Liou, C.-W.;Lan, M.-Y.;Chen, Y.-F.;Tsai, C.-L. |
| 臺大學術典藏 |
2019-07-09T08:15:05Z |
Erratum: ‘Corrigendum to “2017 Taiwan lipid guidelines for high risk patients” [Journal of the Formosan Medical Association (2017) [217–248]’(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
The Writing Group Of 2017 Taiwan Lipid Guidelines For High Risk Patients;Yeh H.-I.;Wu C.-C.;Chen J.-W.;Yu T.-Y.;Lee C.-C.;Tang S.-C.;Liou C.-W.;Chien S.-C.;Su C.-H.;Liu P.-Y.;Chao T.-H.;Wang C.-Y.;Kuo-Liong Chien;Lin T.-H.;Charng M.-J.;Jeng J.-S.;Ueng K.-C.;Li Y.-H.; Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; KUO-LIONG CHIEN; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; Wu C.-C.; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2018-09-10T18:05:35Z |
2017 Taiwan lipid guidelines for high risk patients
|
Li, Y.-H. ; Ueng, K.-C. ; Jeng, J.-S. ; Charng, M.-J. ; Lin, T.-H. ; Chien, K.-L. ; Wang, C.-Y. ; Chao, T.-H. ; Liu, P.-Y. ; Su, C.-H. ; Chien, S.-C. ; Liou, C.-W. ; Tang, S.-C. ; Lee, C.-C. ; Yu, T.-Y. ; Chen, J.-W. ; Wu, C.-C. ; Yeh, H.-I.; JIANN-SHING JENG; KUO-LIONG CHIEN |
| 臺大學術典藏 |
2018 |
Erratum: ‘Corrigendum to “2017 Taiwan lipid guidelines for high risk patients” [Journal of the Formosan Medical Association (2017) [217–248]’(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Chen J.-W.; Wu C.-C.; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients; Li Y.-H.;Ueng K.-C.;Jiann-Shing Jeng;Charng M.-J.;Lin T.-H.;Chien K.-L.;Wang C.-Y.;Chao T.-H.;Liu P.-Y.;Su C.-H.;Chien S.-C.;Liou C.-W.;Tang S.-C.;Lee C.-C.;Yu T.-Y.;Chen J.-W.;Wu C.-C.;Yeh H.-I.;The Writing Group Of 2017 Taiwan Lipid Guidelines For High Risk Patients; Li Y.-H.; Ueng K.-C.; JIANN-SHING JENG; Charng M.-J.; Lin T.-H.; Chien K.-L.; Yu T.-Y.; Lee C.-C.; Tang S.-C.; Liou C.-W.; Chien S.-C.; Su C.-H.; Chao T.-H.; Liu P.-Y.; Wang C.-Y. |
